LOS ANGELES, April 9, 2025 /PRNewswire/ — Agilisium – a leading Data Innovation & Agentic AI partner for the Life Sciences industry, unveiled its domain-trained Insight Generation Agent, designed to unlock insight-led decisions across the spectrum of the life sciences value chain.
This Insights Generation AI Agent is not a one-size-fits-all platform—it’s a configurable intelligence layer purpose-built to address unique challenges of life sciences, enabling teams to extract high-context insights from structured and unstructured data sources. Whether surfacing signals in R&D, summarizing real-world evidence, or curating HCP engagement data, the Insight Generation Agent empowers business users to create and scale their own use cases—with minimal to no support from engineering teams.
Designed for Life Sciences. Tuned for Speed. Trained for accuracy. Built for Customization.
With native support for natural language queries, multi-modal data processing, and enterprise integrations, the agent enables:
Executive Commentary on the launch of Insights Generation AI Agent
“This is more than just a product launch—it’s a shift in how life sciences organizations engage with their own data,” said Raj Babu, Founder & CEO Agilisium. “Our Insight Generation Agent is not only trained to understand data, but the domain context too—delivering high-quality answers and decision support without the latency of traditional analytics cycles.”
“At Agilisium, we believe insight generation & consumption shouldn’t be limited to engineers and analyst,” said Arun Kumar, Global CTO, Agilisium. “This agent enables & empowers business—scientists, marketers, operations leaders—anyone looking to move faster with confidence, grounded in evidence.”
Recognition & Industry Credibility:
Agilisium is:
About Agilisium
Agilisium is one of the leading Data Innovation Partners for the Life Sciences industry. The company delivers cutting-edge solutions that drive impactful change by combining our strong domain expertise with Data, Cloud, GenAI, and Advanced Analytics. Agilisium collaborates with leading pharma and biotech companies to provide data-driven insights and innovative solutions across the value chain, helping accelerate drug discovery, optimize patient care, achieve commercial success, streamline product delivery, and foster collaboration. Learn more at www.agilisium.com
SOURCE Agilisium Consulting
STOCKHOLM, May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories…
Sober.Buzz the Sober Token spreading the good $BUZZ! Sober.Buzz is the cryptocurrency being developed by…
Partners with Company Management and Thoma Bravo to Support NextGen Healthcare’s Growth CHICAGO & SAN…
The company will showcase innovations designed to optimize the oncology care workflow and enable improved…
Investment positions SETWorks for accelerated innovation and expanded impact in disability services KANSAS CITY, Mo.,…
BRAINTREE, Mass. and NEW YORK, May 2, 2025 /PRNewswire/ -- MIB, the life insurance industry's most…